Natural Products for Metabolic Syndrome
Yhiya Amen, Ahmed Othman, Kuniyoshi ShimizuBackground
Metabolic syndrome (MetS) is a multifactorial disorder characterized by central obesity, insulin resistance, dyslipidemia, hypertension, and chronic low-grade inflammation, collectively increasing the risk of cardiovascular disease and type 2 diabetes. Current therapeutic approaches are often limited by their single-target mechanisms, adverse effects, and economic burden. Natural products have emerged as promising therapeutic candidates because of their ability to modulate multiple interconnected pathological pathways involved in MetS.
Key Findings
This editorial highlights recent advances in the discovery and mechanistic evaluation of natural products for the prevention and management of MetS. Evidence from the studies included in this collection demonstrates that diverse bioactive natural compounds can regulate glucose and lipid metabolism, attenuate inflammation and oxidative stress, improve mitochondrial function, and restore metabolic homeostasis. These findings support the concept that natural products may address the complex and interconnected pathophysiology of MetS more effectively than single-target interventions.
Conclusions
Natural products represent a valuable foundation for integrative, systems-based strategies aimed at managing MetS and its associated metabolic complications. However, further efforts are required to overcome challenges related to bioavailability, pharmacokinetic properties, standardization, and clinical translation before their full therapeutic potential can be realized. Continued multidisciplinary research will be essential to advance natural product-based interventions from preclinical discovery to clinical application.